|JNCE -- USA Stock|| |
USD 7.78 0.05 0.64%
Dr. Padmanee Sharma, M.D. Ph.D. is a cofounder of Jounce Therapeutics and currently serves as scientific director and professor in the departments of genitourinary medical oncology and immunology at The University of Texas MD Anderson Cancer Center. Dr. Sharma is a medical oncologist and immunologist, and is currently the principal investigator of several immunotherapy clinical trials, which allow her to further investigate immune responses and pathways that are critical for eliciting antitumor responses and clinical benefit in cancer patients. Dr. Sharma has received numerous awards in her field including a Department of Defense Idea Development Award, a Cancer Prevention Research Institute of Texas Individual Investigator Award, a National Institute of Health R01 Award and an AACRCRISU2C Immunotherapy dream team grant
Sharma holds a Ph.D. in immunology and an M.D. from Pennsylvania State University. She also holds a B.A. in biology and an M.A. in biotechnology from Boston University.